Medical device company Shreis Scalene Therapeutics LLC (SSTx) revealed on Thursday that it will fast-track the manufacture and distribution of the CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN) under US FDA "Enforcement Policy for Sterilizers, Disinfectant Devices and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency."

Following the CE Mark with Class I designation, the company is enabling the expedited manufacture, distribution and sales of SHYCOCAN in all CE-compliant countries/markets, including India.

SHYCOCAN releases a very high concentration of environmentally safe electrons using proprietary Photon-Mediated Electron Emitters (PMEEs) to emit and excite photons with the required kinetic energy. The emanated electron cloud actively 'disarms' air and surface transmission of the Corona family of viruses. The device can be safely deployed in all environments inhabited by people, be it very large or small enclosed spaces, added the company.

The company disclosed attachment of the SARS-CoV-2 to the host cell receptor is mediated by the spike protein (S-protein). The hypercharge electrons flooding exposed areas are attracted to the virus' S-protein, disabling infectivity. Data from lab studies have indicated significant viricidal impact and reduction in an EPA-approved phylogenetic surrogate, resulting in 99.9% reduction in infectivity.